Invention Grant
- Patent Title: Tofacitinib oral sustained release dosage forms
-
Application No.: US14211659Application Date: 2014-03-14
-
Publication No.: US09937181B2Publication Date: 2018-04-10
- Inventor: Scott Max Herbig , Sriram Krishnaswami , Joseph Kushner, IV , Manisha Lamba , Thomas C Stock
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Christian M. Smolizza
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K45/06 ; A61K9/00 ; A61K9/20 ; A61K9/28 ; A61K9/48 ; A61K31/40
Abstract:
The present invention relates to oral sustained release formulations of tofacitinib and pharmaceutical acceptable salts thereof. The formulations described herein have desirable pharmacokinetic characteristics.
Public/Granted literature
- US20140271842A1 TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS Public/Granted day:2014-09-18
Information query
IPC分类:
